My Off-Canvas

Breadcrumb

Inaugural

MolMed Symposium - "Translational Medicine Activities at UC Riverside"

Tuesday, March 26, 2019

Genomics Auditorium and Lobby


Sir Thomas Blundell

Keynote Speaker: Sir Thomas Blundell, F.R.S., F.Med.Sci.

Department of Biochemistry at Cambridge University

"Structural Biology, Bioinformatics and Drug Discovery for Cancer and Tuberculosis: Fighting the Emergence of Resistance"

2019 Symposium Schedule

8:30 a.m.

Registration & Continental Breakfast

9 a.m.

Symposium Opens

Welcome and Introduction to the Center for Molecular and Translational Medicine at UCR
Dean Deborah Deas, The Mark & Pam Rubin Dean, UC Riverside School of Medicine
Chief Executive Officer for Clinical Affairs
and the organizing committee

9:15 a.m. — 11:15 p.m.

Novel Screening Approaches for Small Molecules and Antibodies

Chair: Michael Pirrung, Ph.D.

Sika Zheng

UC Riverside School of Medicine
"A novel robust screening strategy for NMD-modulatory molecules"

Jiayu Liao

Bourns College of Engineering, UC Riverside
"Novel strategy of developing therapeutics for anti-influenza virus and drug resistant strains by targeting host factors"

Xin Ge

Bourns College of Engineering, UC Riverside
"A Monoclonal Antibody Treatment for Neuropathic Pain"

Robert Damoiseaux

UCLA
"Building a Drug Discovery and Development Pipeline at UCLA"

11:15 a.m. — 11:30 a.m.

Coffee Break

11:30 a.m. - 1 p.m.

Fragment- and Structure-Based Drug Design

Chair: Jiayu Liao, Ph.D.

Rong Hai

College of Natural and Agricultural Sciences, UC Riverside
"Identification of Small Molecule Inhibitors of Zika Virus Infection"

Jeff Perry

College of Natural and Agricultural Sciences, UC Riverside
"Targeting neuroblastoma and age-related macular degeneration through structure-based drug design efforts"

Dimitrios Morikis

Bourns College of Engineering, UC Riverside
"Structure- and Systems-based Drug and Biosensor Discovery for Complement System Mediated Diseases"

1:00 - 2:00 p.m.

Lunch buffet and Posters viewing

2:15 - 3:30 p.m.

UCR and UC-wide Translational Medicine Initiatives and Opportunities

Chair: Maurizio Pellecchia, Ph.D.

Rosibel Ochoa

Vice Chancellor Research and Economic Development, UC Riverside
"The MRB1 Incubator space and other initiatives supporting UCR spin off companies in translational medicine"

Joseph Wagner

UC San Francisco
"The UC-Wide Drug Discovery Consortium"

Michael Gilson

UC San Diego
"The UCSD CDD Core and Initiatives"

Slava Parno

COVANCE
"EPDS and Marketplace by Covance"

3:30 - 4 p.m.

Coffee Break and Poster Session

4 - 5 p.m.

Towards Novel UCR Therapeutics

Chair: Jeff Perry, Ph.D.

Maurizio Pellecchia

School of Medicine, UC Riverside
"Targeting tumor metastases via the EphA2 receptor: changing the face of chemotherapy"

Michael Pirrung

College of Natural and Agricultural Sciences, UC Riverside
"Anticancer Proteasome Inhibitors"

Learn more about Michael Pirrung's research

5 - 6 p.m.

Keynote Lecture
Sir Thomas Blundell, F.R.S., F.Med.Sci.,

Department of Biochemistry at Cambridge University
"Structural Biology, Bioinformatics and Drug Discovery for Cancer and Tuberculosis: Fighting the Emergence of Resistance"

6 - 7 p.m.

Award Presentations & Reception

Light refreshments will be served

Search